ID: ALA3357920

Max Phase: Preclinical

Molecular Formula: C10H12N4O7

Molecular Weight: 300.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)OCCOCn1c(=O)n(C)c(=O)c2c1no[n+]2[O-]

Standard InChI:  InChI=1S/C10H12N4O7/c1-6(15)20-4-3-19-5-13-8-7(14(18)21-11-8)9(16)12(2)10(13)17/h3-5H2,1-2H3

Standard InChI Key:  NKIIWGIIJRXHRY-UHFFFAOYSA-N

Associated Targets(Human)

WISH 126 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Vesicular stomatitis virus 4460 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.23Molecular Weight (Monoisotopic): 300.0706AlogP: -2.14#Rotatable Bonds: 5
Polar Surface Area: 132.50Molecular Species: NEUTRALHBA: 10HBD: 0
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: -2.14CX LogD: -2.14
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.35Np Likeness Score: -0.51

References

1. Xu X, Wang J, Yao Q..  (2015)  Synthesis and quantitative structure-activity relationship (QSAR) analysis of some novel oxadiazolo[3,4-d]pyrimidine nucleosides derivatives as antiviral agents.,  25  (2): [PMID:25515560] [10.1016/j.bmcl.2014.11.065]

Source